Methandrostenolone is a synthetic anabolic steroid, widely known by its brand name Dianabol. It was one of the first oral steroids developed specifically to enhance athletic performance, and it remains one of the most recognized anabolic steroids in the world. It is classified as a Schedule III controlled substance in the United States and is no longer approved for medical use.
How Methandrostenolone Works
Methandrostenolone is a modified form of testosterone. Its chemical structure (C20H28O2) includes two key changes that make it distinct from natural testosterone. First, a methyl group is added at a specific position on the molecule, which prevents the liver from breaking it down too quickly. This is what makes it effective when taken as a pill, unlike testosterone itself, which is largely destroyed during digestion. Second, an additional structural change shifts its balance toward tissue-building (anabolic) effects rather than masculinizing (androgenic) effects, though it retains both properties to some degree.
Once absorbed, methandrostenolone binds to the same receptors that testosterone uses, promoting protein synthesis in muscle tissue, increasing nitrogen retention, and enhancing glycogen storage. These effects translate to faster muscle growth and quicker recovery between workouts, which is why it became so popular among bodybuilders and strength athletes from the 1960s onward. The drug has a relatively short half-life, typically estimated at 3 to 6 hours, meaning it clears the body quickly but also requires frequent dosing to maintain stable blood levels.
Origins and Legal Status
Methandrostenolone was developed in the late 1950s by Ciba Pharmaceuticals and initially marketed under the brand name Dianabol. It was originally prescribed for conditions like osteoporosis and muscle-wasting diseases, but its performance-enhancing effects quickly drew attention in competitive sports, particularly in Olympic weightlifting and bodybuilding. By the 1980s, growing evidence of its side effects led to its removal from the U.S. pharmaceutical market.
Today, anabolic steroids including methandrostenolone are listed as Schedule III controlled substances under the U.S. Controlled Substances Act. Possessing or distributing them without a valid prescription carries criminal penalties. The drug is also banned by virtually every major sports organization, including the World Anti-Doping Agency. Despite this, it remains widely available on the black market and through underground labs, often under the names Dianabol, Dbol, or metandienone.
Liver Damage From Oral Use
The same structural modification that makes methandrostenolone survivable in pill form is also what makes it dangerous to the liver. This modification, known as 17-alpha alkylation, forces the liver to process a compound it cannot easily break down. Over time, this creates stress on liver cells and bile flow.
Oral anabolic steroids with this modification have been linked to a range of liver problems: prolonged cholestasis (where bile cannot flow properly, causing jaundice), a condition called peliosis hepatis (blood-filled cysts in the liver), liver cell tumors, and in rare cases hepatocellular carcinoma. Paradoxically, standard liver enzyme blood tests may not fully reflect the damage. Liver enzymes like ALT and alkaline phosphatase often rise only modestly, sometimes staying under two to three times the normal range, even in the presence of significant jaundice. This means liver injury can be more advanced than blood work suggests.
The cholestatic pattern seen with these steroids is similar to what occurs in some pregnant women or in people sensitive to high-dose estrogen medications. It may involve inherited variations in bile transport proteins that make certain individuals more vulnerable.
Effects on Cholesterol and Heart Health
Methandrostenolone has a pronounced negative effect on blood lipids, and this may be its most underestimated risk. Anabolic steroid use can reduce HDL (“good”) cholesterol by more than 90% while increasing LDL (“bad”) cholesterol by roughly 50%. In one documented case of a bodybuilder using anabolic steroids, HDL cholesterol dropped to 0.1 mmol/L, essentially eliminating the body’s primary mechanism for clearing cholesterol from arterial walls.
These changes dramatically accelerate the development of atherosclerosis, the buildup of plaque in arteries. For someone using methandrostenolone over repeated cycles, this lipid disruption accumulates over time and contributes to elevated long-term risk of heart attack and stroke, even in young, otherwise healthy individuals. The cardiovascular effects tend to reverse after stopping use, but the degree and timeline of recovery depend on how long and how heavily the drug was used.
Estrogenic Side Effects
Methandrostenolone partially converts into an estrogen-like compound in the body through the aromatase enzyme, the same enzyme that normally converts testosterone into estradiol. The resulting metabolite, 17-alpha-methylestradiol, produces estrogenic effects that can catch users off guard. These include water retention, bloating, and gynecomastia (breast tissue growth in men).
This estrogenic conversion is one reason methandrostenolone tends to produce rapid weight gain that is partly water rather than pure muscle. Many users attempt to counteract these effects with anti-estrogen drugs, though this adds another layer of pharmacological complexity and its own set of side effects.
Other Physical Side Effects
Beyond the liver and cardiovascular system, methandrostenolone carries the full range of androgenic side effects common to anabolic steroids. These include acne, accelerated male-pattern baldness in those genetically predisposed, and oily skin. In women, even short-term use can cause deepening of the voice, facial hair growth, and menstrual irregularities, some of which may not fully reverse after stopping.
The drug also suppresses the body’s natural testosterone production through a feedback loop involving the brain and testes. During use, the body recognizes excess androgens in the bloodstream and shuts down its own hormone production. After a cycle ends, it can take weeks to months for natural testosterone levels to recover, and some users experience prolonged low testosterone with symptoms like fatigue, depression, and sexual dysfunction. In adolescents, anabolic steroid use can prematurely close growth plates in bones, permanently limiting adult height.
Detection in Drug Testing
Despite its short half-life, methandrostenolone and its metabolites can be detected in urine for a surprisingly long window. Research on transdermal application found that the drug or its breakdown products remained detectable for 10 to 14 days after administration, with some metabolites appearing in urine within hours of the first dose. Standard anti-doping tests used by sports organizations specifically screen for these metabolites, making it a high-risk choice for tested athletes. More advanced testing methods, including those targeting long-term metabolites, have extended detection windows even further in recent years.